Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus Vaccines

Routine infant immunization with live, oral rotavirus vaccines (LORVs) has had a major impact on severe gastroenteritis disease. Nevertheless, in high morbidity and mortality settings rotavirus remains an important cause of disease, partly attributable to the sub-optimal clinical efficacy of LORVs i...

詳細記述

書誌詳細

主要な著者:	William P. Hausdorff, Jessica Price, Frédéric Debellut, Jessica Mooney, Andrew A. Torkelson, Khatuna Giorgadze, Clint Pecenka
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2022-01-01
シリーズ:	Vaccines
主題:	rotavirus gastroenteritis product preferences cost-effectiveness combination vaccines value proposition
オンライン･アクセス:	https://www.mdpi.com/2076-393X/10/2/149
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!